Keri Wallace, Julie Uchitel, Lyndsey Prange, Joan Jasien,
Melanie Bonner, Richard D’Alli, Gary Maslow and Mohamad A. Mikati. Characterization of Severe and Extreme
Behavioral Problems in Patients with Alternating Hemiplegia of Childhood. Pediatric Neurology. In press.
Highlights
•
About 41% of AHC patients have severe (26%) or extreme (15%)
behaviors.
•
Genotype, age, puberty, and degree of ID do not correlate
with behavior severity.
•
Medication adverse events may trigger behavioral problems,
including psychosis.
•
Efficacy of medications for behavioral control varies among
individual patients.
•
Collaboration with mental health professionals aids in
management of AHC.
Abstract
Background
Alternating Hemiplegia of Childhood (AHC) often manifests
severe or extreme behavioral problems, the nature of which remain to be fully
characterized.
Methods
We analyzed 39 consecutive AHC patients for occurrence of
behavioral problems and categorized those by severity: mild (not requiring
intervention), moderate (requiring intervention but no risk), severe (minor
risk to self and/or others) and extreme (major risk). We then analyzed
behavioral manifestations, concurrent morbidity, and medication responses in
patients with severe or extreme symptoms.
Results
Two patients had mild behavioral problems, 5 moderate, 10
severe, 6 extreme and 16 none. Extreme cases exhibited disruptive behaviors
escalating to assaults. Triggers, when present, included peer-provocation, low
frustration tolerance, limits set by others, and sleep disruption. Reversible
psychotic symptoms occurred in 2 patients; in one triggered by infection and
trihexyphenidyl, and in another triggered by sertraline. Of the 16 patients
with severe/extreme symptoms, 13 had concurrent neuropsychiatric diagnoses.
Occurrence of severe/extreme symptoms did not correlate with age, puberty,
severity of intellectual disability or mutation status (p>0.05). A
multidisciplinary team including mental-health professionals co-managed all
patients with severe/extreme symptoms with behavioral therapy and/or
medications. When considering medications prescribed to a number of patients
greater than 4, medicines that demonstrated efficacy or partial efficacy in
> 50% of patients were alpha-adrenergic agonists and SSRIs.
Conclusion
AHC patients often (41%) experience severe/extreme
behavioral problems and, rarely, medication-triggered psychotic symptoms. These
observations are consistent with current understanding of underlying AHC brain
pathophysiology. Increasing awareness of these behavioral problems facilitates
AHC management and anticipatory guidance.
No comments:
Post a Comment